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Opa b s t r a c t
Objectives: Physicians lack clear guidance about adaptation of clinical practice guidelines for elderly
institutionalized patients with diabetes. In a large long-term care facility, a diabetes management ﬂow
sheet was trialed to determine which clinical parameters were found useful by clinicians in the man-
agement of diabetes in that setting.
Methods: Clinical practice guidelines for diabetes management were reviewed with attending physicians.
Diabetes management ﬂow sheets were distributed for all patients coded as having diabetes on their
most recent minimum data sets. After a period of 14 months, ﬂow sheet completion rates were ascer-
tained and physicians were surveyed regarding the utility of the ﬂow sheet.
Results: Initialﬂowsheet datawere completed in full or inpart for only 57% of the 121 study subjects; 39% of
the subjects died within 14 months. Quarterly follow-up data were completed for 58% of the ﬂow sheets.
Conclusions: The diabetes management ﬂow sheet was not found to be useful by attending physicians as
a chronic-disease management tool.
 2015 Canadian Diabetes Association
r é s u m é
Objectifs : Les médecins manquent d’orientation claire concernant l’adaptation des lignes directrices de
pratique clinique pour le suivi des patients âgés hébergés souffrant de diabète. Dans un établissement de
soins de longue durée, une feuille de suivi du diabète a été mise à l’essai par les cliniciens concernés par la
prise en charge du diabète dans cemilieu pour déterminer quels paramètres cliniques se sont avérés utiles.
Méthodes : Les médecins traitants ont passé en revue les lignes directrices de pratique clinique en
matière de prise en charge du diabète. Les feuilles de suivi du diabète ont été distribuées à tous les
patients classiﬁés diabétiques selon les données les plus récentes du ﬁchier minimal. Après une période
de 14 mois, les taux d’achèvement de la feuille de suivi ont été déterminés et les médecins ont été
interrogés sur l’utilité de la feuille de suivi.
Résultats : Seulement 57 % des 121 sujets de l’étude ont rempli entièrement ou partiellement les données
initiales de la feuille de suivi; 39 % des sujets sont morts dans les 14 mois. Trimestriellement, les données
de suivi ont été complétées pour 58 % des feuilles de suivi.
Conclusions : Les médecins traitants n’ont pas trouvé utile la feuille de suivi du diabète comme outil à la
prise en charge de la maladie chronique.
 2015 Canadian Diabetes Association
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Open access under CC BY-NC-ND license.Introduction concerning diabetes management consist mainly of avoidance ofBackground
In the long-term care (LTC) setting, there are no scheduled visits
for management of chronic disease, and recommendations, Division of Long Term Care,
75 Bayview Avenue, Toronto,
en access under CC BY-NC-ND licensethe symptoms of hyperglycemia and hypoglycemia. This study
explores use of a diabetes management ﬂow sheet in LTC as an aid
to the provision of diabetes care.Methods
Study design
This was a cross-sectional survey following an educational
intervention and the implementation of a ﬂow sheet in LTC. The.
Table 1
Diabetes ﬂow sheet completion
Measure M (SD) Total measures
completed, n (%)
Total obtained
from FS, n (%)
Reasons incomplete: Total selected, n (%)
NR R U NG
3-month targets
Fasting glucose 6.2 (1.6) 87 (72%) 66 (55%) 34 (28%)
A1C .07 (.05) 92 (76%) 55 (45%) 29 (24%)
Blood pressure 127/70 65 (54%) 65 56 (46%)
Weight (kg) 69.6 (13.7) 61 (50%) 61 60 (50%)
BMI 23.7 (5.1) 41 (34%) 41 80 (66%)
Foot exam . 46 (38%) 46 73 (60%) 1 (1%) 1 (1%)
Yearly targets
Monoﬁlament 10 g . 23 (19%) 23 79 (65%) 6 (5%) 11 (9%) 2 (2%)
LDL-C 1.9 (.67) 71 (58.5%) 55 (45%) 46 (38%) 1 (1%) 3 (2.5%)
Total cholesterol/HDL-C 3.5 (1.1) 72 (59.5%) 56 (46%) 45 (37%) 1 (1%) 3 (2.5%)
Albumin/creatinine 30.7 (72.8) 63 (52%) 45 (37%) 53 (43.5%) 3 (2.5%) 2 (2%)
eGFR 70.0 (38.6) 52 (43%) 50 (41%) 69 (57%)
Dilated eye exam . 50 (41%) 50 60 (50%) 5 (4%) 1 (1%) 5 (4%)
Referral to dietitian . 62 (51%) 62 . . . .
Other referrals . 13 (11%) 13 . . . .
Inﬂuenza vaccine . 55 (45%) 55 65 (54%) 1 (1%)
A1C, Glycated hemoglobin; BMI, body mass index; eGFR, estimated glomerular ﬁltration rate; FS, ﬂow sheet; HDL, high density lipoprotein; LDL-C, low density lipoprotein;M,
mean; NG, prognosis of less than 2-3 years, prevention of complications or tight control not a goal of care; NR, not reported; R, patient refused exam or investigation; SD,
standard deviation; U, patient unable to communicate.
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Toronto, Ontario, has 190 nursing-home beds and 320 complex
continuing-care beds. Patients are eligible for admission if they
served overseas in a theatre of war (limited toWorldWar II and the
Korean War). The protocol for the study was approved by the SHSC
Research Ethics Board.
Inclusion criteria
The study subjects were a convenience sample of all admitted
patients coded on the minimum data set (MDS) as having diabetes
during their most recent assessments. The diabetes patient list was
checked independently against a pharmacy database to ensure that
all patients being treated for diabetes were included. Diabetes
patients on diet control only were included if that diagnosis was
listed on the MDS assessment.
The education intervention
All 10 attending physicians in the division of LTC at SHSC were
given a copy of the American Medical Directors Association Clinical
Practice Guidelines, Diabetes Management in the Long-Term Care
Setting, and the 2008 clinical practice guidelines of the Canadian
Diabetes Association (1,2). A 1-hour diabetes chronic-disease man-
agement educational seminar, facilitated by the author, was held for
the attending physicians to review the goals of diabetes care for the
study population and the ﬂow sheet parameters to be included.
Flow sheet design and implementation
The diabetes management ﬂow sheet used for this study incor-
porated all data elements required for physicians to bill the K030
Diabetes Management code (3). The fee code K030, implemented
only in the province of Ontario, requires a ﬂow sheet that tracks
lipids, cholesterol, glycated hemoglobin (A1C), urinalysis, blood
pressure, fundal examination, peripheral vascular examination,
weight and body mass index (BMI) and medication dosage. Flow
sheet parameters related to self-management were excluded
because of the cognitive and functional disabilities of the patients.
Risk factors and comorbidities were also excluded because they are
documented elsewhere in the health record.
For each of the study participants on their units, the attending
physicians were asked to complete and update every 3 months thediabetes chronic disease management ﬂow sheet (Appendix 1). For
any incompletedata item, reasons for lackofdatawere tobecodedas:
 unable to communicate
 refused exam or investigation or
 prevention of complications or tight control not a goal of care.
Items left blank were coded NR, not recorded.
After 16months, the diabetesmanagement ﬂow sheet datawere
abstracted on chart review of current and deceased subjects.
Statistical methods
Descriptive datawere compiled on the basis of the percentage of
completion of the items on the diabetes ﬂow sheet. Mean values
and standard deviations (SDs) of all performance indicators were
computed using statistical functions in Microsoft Excel 2007. All
additional statistical tests were performed using the software
program R (v. 2.11.1).
Results
The initial sample size was 117. Over the course of the study, an
additional 4 new patients were enrolled, for a total of 121 patients.
Their average age was 87.4 (SD¼5.0), ranging from 71 to 105. Their
average length of stay in the long-term care unit was approximately
4.2 years (SD¼2.8). The gender was >90% male.
Within 14 months of the study’s commencement, 39% of the
patients had expired. Flow sheet data were available for 43% of the
expired patients. For the remaining active patients, 66% had ﬂow
sheets available. In total, 57% of the original sample had ﬂow sheets
available (69 ﬂow sheets completed). For expired patients, 1 pre-
viously completed record could not be found. For 26 expired par-
ticipants, the ﬂow sheet could not be located in the chart.
A detailed breakdown of percentage of completion of spe-
ciﬁc performance indicators in the diabetes ﬂow sheet can be
seen in Table 1. For laboratory values fasting glucose glycated
hemoglobin (A1C), low-density lipoprotein-cholesterol [LDL-C],
ratio of total cholesterol and high-density lipoprotein-choles-
terol (HDL-C), and estimated glomerular ﬁltration rate [e-GFR]),
if no information was provided by physicians on the ﬂow sheet,
researchers extracted ﬂow sheet data from electronic patient
records, when available.
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The ambulatory diabetes chronic care management model
facilitates planning and coordination among providers and involves
the patients in self-management, with the objective of preventing
complications and delaying progression of the disease. Flow sheets
are used in the context of periodic scheduled ofﬁce visits to ensure
implementation of guidelines. Physicians in LTC visit the facility
periodically to manage acute changes in condition, but commonly,
they do not have a routine or schedule structured around chronic
disease management.
The ﬂow sheet parameters mandated for payment of a fee for
this service were developed for a younger population. Although
prior research concerning diabetes ﬂow sheets has found that
although they are useful tools in improving physicians’ adherence
to diabetes care guidelines, they do not improve outcome targets
for middle aged (4) or older (5) populations (mean ages of 59.5 and
72, respectively).
Flow sheet parameters also monitor the use of angiotensin
converting enzyme inhibitors, angiotensin receptor blockers and
statins for treatment of hypertension and/or hyperlipidemia. Most
evidence for these interventions comes from trials in much
younger populations. In the Action to Control Cardiovascular Risk
in Diabetes (ACCORD), the United Kingdom Prospective Diabetes
Study (UKPDS), the Action in Diabetes and Vascular Disease:
Preterax and the Diamicron Modiﬁed Release Controlled Evalua-
tion (ADVANCE) and the Veteran Affairs Diabetes Trials (VADT)
trials, the average ages of the participants were 62, 54, 66 and 60,
respectively (6e9). For this study population, death is expected,
on average, within 2 years of admission. Beneﬁt in terms of pre-
vention of complications is unlikely, but risk for harm from pol-
ypharmacy is increased.
In this study, if ﬂow sheets were missing parameter values,
physicians were to indicate why they were not completed or not
begun (Table 1). The most common reason for missing ﬂow sheet
itemswas the physicians’ not ordering or administering the tests. In
order to understand the lack of completion of ﬂow sheet parame-
ters, attending physicians were surveyed after project completion.
They were asked to indicate on a Likert rating scale (from 1 to 5)
how useful they found a particular ﬂow sheet parameter in clinical
decision making (Figure 1).Figure 1. Physicians’ self-reported usefulness of ﬂow sheet parameters in clinical
decision making. Values (gray bars) represent mean scores based on the Likert rating
scale (1 ¼ useless, 5 ¼ useful) þ/ SEM (error bars). A1C, Glycated hemoglobin; BP,
blood pressure; BMI, body mass index; e-GFR, estimated glomerular ﬁltration rate;
HDL-C, high-density lipoprotein-cholesterol; LDL-C, low-density lipoprotein-
cholesterol.Physicians valued the A1C parameter most in clinical decision
making, followed by blood pressure and glucose. The ﬂow sheet
parameters that were least valued were BMI and the mono-
ﬁlament test. Weight and foot examinations were also deemed
less valuable than the dilated eye exam and all other laboratory
tests (LDL-C, total cholesterol/HDL-C, ratio of albumin/creatinine,
eGFR).
Some reasons given for physicians’ noncompliance in ordering
laboratory tests and/or documenting ﬂow sheet parameters were:
“It is so much easier in the ofﬁce because it (the ﬂow sheet) is all
done for you.”
“I didn’t bother with the foot exam; you have to get the patient
back into bed, shoes and socks off, and no staff are around to
help.”
“I just go by the fasting glucose.”
Because prevention of complications requires a longer time horizon
that patients have in LTC, monitoring and treatment of lipids and
weight are not recommended. Separate documentation of foot
examinations would duplicate the skin assessments already
mandated in LTC; detailing the effect of diabetes on peripheral
circulation and sensation in itself does not affect treatment
decisions near the end of life.
Chronic disease management in LTC
The following list shows how elements of organization of dia-
betes care are already incorporated into existing LTC regulations
and documentation systems (10):
Recognize: screening for risk factors is part of the MDS assess-
ment; glucose and creatinine values are universally obtained on
admission to LTC.
Register: a register or list of all patients with diabetes in a facility
is easily extracted from the MDS.
Resource: self-management is limited by the cognitive deﬁcits or
communication challenges of most patients in LTC. The system for
review of weight, BMI and diet is already in place through the
mandated quarterly review by the dietitian, who is also available
for patient counselling.
Relay: information to assist collaboration among healthcare
providers is available through the healthcare record, discussed at
interdisciplinary case conferences and shared with the patient or
substitute decision maker at case conferences and during informal
visits.
Recall: laboratory values, consultants’ reports and physicians’
orders are usually documented in paper form in the LTC record.
Chronic disease management tools as performance indicators
In the United Kingdom, 4 parameters (A1C, blood pressure,
serum creatinine and total cholesterol) used in this ﬂow sheet were
removed from the quality and outcomes framework in 2011
because achievement of these indicators was greater than 95% and
was stable over time (11). Also, patients were exempted from the
denominator of “extreme frailty”; in an LTC facility patients would
have to be at least moderately frail (level 6.0 on the Rockwood
scale) to be admitted (12).
Payment of a diabetes management fee requiring ﬂow sheet
completion assumes that the net health beneﬁts of incentives are
greater than the costs of obtaining the data. Table 3 shows the costs
per 100 patients per year if 4 of the laboratory values had been
obtained and the ﬂow sheet completed for a year.
Implementation of the ﬂow sheet was not successful because it
duplicated other processes and contained parameters not relevant
to the population. The additional workload did not assist the
Table 2
Duplication of parameter values in the health records
Parameter Requirements Location of data
Fasting glucose Daily as part of medication monitoring Glucose monitoring ﬂow sheet
A1C Ordered as part of standard admission orders for people with diabetes Electronic laboratory data
Blood pressure Monthly to meet nursing home standards Vital signs ﬂow sheet
Weight Monthly to meet nursing home standards Vital signs ﬂow sheet
BMI . Dietitian quarterly assessment
Foot exam Skin assessment required quarterly for nursing home standards and MDS Skin assessment form
Foot exam performed by physician as part of admission and annual assessment Admission/annual assessment form
Monoﬁlament or vibration feet May be part of admission/annual exam Admission/annual form
Lipid values Electronic laboratory data
Albumin/creatinine ratio . Electronic laboratory data
e-GFR . Electronic laboratory data
Referral to dietitian Quarterly for nursing home standards Dietitian quarterly assessment
Dilated eye exam . Consultation note
Inﬂuenza vaccine Yearly for nursing home standards Immunization data record
Medications Administration of each dose recorded as part of nursing practice Medication administration record
New orders and quarterly medication review kept with doctors’ orders Medication review record
A1C, Glycated hemoglobin; BMI, body mass index; e-GFR, estimated glomerular ﬁltration rate; MDS, minimum data set.
E. Williams, A. Curtis / Can J Diabetes 39 (2015) 273e277276physicians in meeting the limited goals of minimizing hypoglyce-
mia and hyperglycemia in this population. The time required to
assemble these data onto a paper ﬂow sheet detracts from the time
available for direct care. In this study, there was no discernible net
health beneﬁt to justify the cost of ﬂow sheet completion.Alternatives to a ﬂow sheet
Unfortunately, laboratory values, consultants’ reports and phy-
sicians’ orders are not imported intomost electronicmedical record
systems used in Ontario; therefore, there is no ability to assemble a
few pertinent ﬂow sheet parameters electronically into a single
document. The duplication in other parts of the record of ﬂow sheet
data is shown in Table 2. Instead of a ﬂow sheet, patients in LTC
would beneﬁt from a simple monitoring system linked to the
quarterly medication review. This review is a collaboration be-
tween pharmacists and attending physicians and is mandated in
Ontario LTC facilities. The required data elements would be limited
to A1C, serum creatinine, capillary glucose and blood pressure and,
ideally, would be assembled electronically from the laboratory and
electronic record systems at no additional cost. Frequency of
obtaining these parameters could be speciﬁed in the admission
orders and timed to align with the quarterly review. Diabetes
medication adjustments and orders for treatment or monitoring
would then be made as part of the medication review process. If a
template cannot be created, the pharmacists or physicians could
just reference those few values from the paper and electronic
records when reviewing diabetes treatment.
For patients in LTC facilities, several other chronic diseases and
comorbidities must also be managed. Simple reminders integrated
with current documentation systems would ensure that the
essentials of care are covered efﬁciently.Table 3
The costs per 100 patients per year, whether 4 of the laboratory values had been
obtained and the ﬂow sheets completed for 1 year
Parameter (fee for service) Cost per unit Frequency Cost per year
A1C ($10.85) $1085 Q 3 months $3255
Lipid proﬁle ($13.75) $1375 Yearly $1375
e-GFR ($2.50) $250 Yearly $250
Albumin/creatinine ratio ($8.00) $800 Yearly $800
K030 ($37.00) $3700 Q 3 months $11 100
Q040 ($75.00) $7500 Once per year $7500
Total $14 710 . $24 280
A1C, Glycated hemoglobin; e-GFR, estimated glomerular ﬁltration rate.Acknowledgements
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Appendix 1
Sample diabetes ﬂow sheet
Date recorded (MM/DD/YYYY)
Parameter Value
3 month parameters (target values)
Fasting glucose (4e7 mmol/L)
A1C (<8.6 mmol/L)
Blood pressure (<130/80 mm Hg)
Weight kg
BMI (<25 kg/m2)
Foot exam (pulses, skin, bony abnormalities, etc.)
Yearly parameters (target values)
Monoﬁlament 10 g or vibration of great toes
LDL-C (<2.5 mmol/L)












Codes to use when ﬂow sheet incomplete:
Unable to communicate U
Refuses exam or investigation R
Prognosis less than 2e3 years NG
Prevention of complications or tight control not a goal of care
Not done by physician NR
A1C, Glycated hemoglobin; ACE, angiotensin-converting enzyme inhibitors; ARB,
angiotensin receptor blocker; ASA, acetylsalicylic acid; BMI, body mass index; e-GFR,
estimated glomerular ﬁltration rate; HDL, high-density lipoprotein; LDL, low-
density lipoprotein; NG, prognosis less than 2-3 years, prevention of complica-
tions or tight control not a goal of care; NR, not reported; R, patient refused exam or
investigation; U, patient unable to communicate.
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